Pharming Group N.V.
NASDAQ: PHAR0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Fabrice Chouraqui
- Employees
- 404
- Headquarters
- Leiden, Netherlands
- IPO year
- 2020
- Market cap
- $916.7M
- Website
- https://www.pharming.com
Loading PHAR…
Loading profile data…Frequently asked questions about PHAR
What does Pharming Group N.V. (PHAR) do?
Pharming Group N.V. is a biopharmaceutical company dedicated to the creation and commercialization of protein replacement therapies and precision medicines. The firm concentrates its efforts on addressing rare diseases and critical unmet medical needs across the United States, Europe, and other international markets. Its primary commercialized p...
Where does PHAR trade?
Pharming Group N.V. (PHAR) trades on the NASDAQ Global Market.
What sector is PHAR in?
Pharming Group N.V. (PHAR) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Pharming Group N.V.?
Fabrice Chouraqui is the chief executive officer of Pharming Group N.V. (PHAR).
Where is Pharming Group N.V. headquartered?
Pharming Group N.V. is headquartered in Netherlands.
Does PHAR pay a dividend?
Pharming Group N.V. (PHAR) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PHAR go public?
Pharming Group N.V. (PHAR) completed its initial public offering in 2020.
Is PHAR an ADR?
Yes — PHAR is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Pharming Group N.V. reporting and dividends follow the underlying issuer.